Berntorp Erik
Centre for Thrombosis and Haemostasis, Malmö University Hospital, Malmö, Sweden.
Thromb Res. 2007;120 Suppl 1:S3-4. doi: 10.1016/j.thromres.2007.03.010. Epub 2007 May 23.
In 1926, Erik von Willebrand, a Finnish physician, published the first manuscript describing a haemorrhagic disorder in people who were living on the Aland islands off the coast of Finland. This disorder is now known by the name of its discoverer. Since this early observation, von Willebrand disease has been extensively studied. Today, we know the structure and function of the von Willebrand factor and much of its molecular biology. With the availability of safe and effective products, the treatment of von Willebrand disease is continually improving.
1926年，芬兰医生埃里克·冯·维勒布兰德发表了第一篇描述芬兰海岸外奥兰群岛居民出血性疾病的手稿。这种疾病现在以其发现者的名字命名。自这一早期观察以来，冯·维勒布兰德病得到了广泛研究。如今，我们已经了解了冯·维勒布兰德因子的结构和功能及其大部分分子生物学知识。随着安全有效产品的出现，冯·维勒布兰德病的治疗方法也在不断改进。
